NKG2D blockade prevents autoimmune diabetes in NOD mice

Kouetsu Ogasawara; Jessica A. Hamerman; Lauren R. Ehrlich; Helene Bour-Jordan; Pere Santamaria; Jeffrey A. Bluestone; Lewis L. Lanier

doi:10.1016/j.immuni.2004.05.008

NKG2D blockade prevents autoimmune diabetes in NOD mice

Kouetsu Ogasawara, Jessica A. Hamerman, Lauren R. Ehrlich, Helene Bour-Jordan, Pere Santamaria, Jeffrey A. Bluestone, Lewis L. Lanier

Research output: Contribution to journal › Article

241 Citations (Scopus)

Abstract

NKG2D is an activating receptor on CD8⁺ T cells and NK cells that has been implicated in immunity against tumors and microbial pathogens. Here we show that RAE-1 is present in prediabetic pancreas islets of NOD mice and that autoreactive CD8⁺ T cells infiltrating the pancreas express NKG2D. Treatment with a nondepleting anti-NKG2D monoclonal antibody (mAb) during the prediabetic stage completely prevented disease by impairing the expansion and function of autoreactive CD8⁺ T cells. These findings demonstrate that NKG2D is essential for disease progression and suggest a new therapeutic target for autoimmune type I diabetes.

Original language	English
Pages (from-to)	757-767
Number of pages	11
Journal	Immunity
Volume	20
Issue number	6
DOIs	https://doi.org/10.1016/j.immuni.2004.05.008
Publication status	Published - 2004 Jun 1
Externally published	Yes

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Infectious Diseases

Access to Document

10.1016/j.immuni.2004.05.008

Fingerprint Dive into the research topics of 'NKG2D blockade prevents autoimmune diabetes in NOD mice'. Together they form a unique fingerprint.

Cite this

Ogasawara, K., Hamerman, J. A., Ehrlich, L. R., Bour-Jordan, H., Santamaria, P., Bluestone, J. A., & Lanier, L. L. (2004). NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity, 20(6), 757-767. https://doi.org/10.1016/j.immuni.2004.05.008

@article{ebc51be95d6740de89e6cf1960a4bb69,

title = "NKG2D blockade prevents autoimmune diabetes in NOD mice",

abstract = "NKG2D is an activating receptor on CD8+ T cells and NK cells that has been implicated in immunity against tumors and microbial pathogens. Here we show that RAE-1 is present in prediabetic pancreas islets of NOD mice and that autoreactive CD8+ T cells infiltrating the pancreas express NKG2D. Treatment with a nondepleting anti-NKG2D monoclonal antibody (mAb) during the prediabetic stage completely prevented disease by impairing the expansion and function of autoreactive CD8+ T cells. These findings demonstrate that NKG2D is essential for disease progression and suggest a new therapeutic target for autoimmune type I diabetes.",

author = "Kouetsu Ogasawara and Hamerman, {Jessica A.} and Ehrlich, {Lauren R.} and Helene Bour-Jordan and Pere Santamaria and Bluestone, {Jeffrey A.} and Lanier, {Lewis L.}",

year = "2004",

month = jun,

day = "1",

doi = "10.1016/j.immuni.2004.05.008",

language = "English",

volume = "20",

pages = "757--767",

journal = "Immunity",

issn = "1074-7613",

publisher = "Cell Press",

number = "6",

}

TY - JOUR

T1 - NKG2D blockade prevents autoimmune diabetes in NOD mice

AU - Ogasawara, Kouetsu

AU - Hamerman, Jessica A.

AU - Ehrlich, Lauren R.

AU - Bour-Jordan, Helene

AU - Santamaria, Pere

AU - Bluestone, Jeffrey A.

AU - Lanier, Lewis L.

PY - 2004/6/1

Y1 - 2004/6/1

N2 - NKG2D is an activating receptor on CD8+ T cells and NK cells that has been implicated in immunity against tumors and microbial pathogens. Here we show that RAE-1 is present in prediabetic pancreas islets of NOD mice and that autoreactive CD8+ T cells infiltrating the pancreas express NKG2D. Treatment with a nondepleting anti-NKG2D monoclonal antibody (mAb) during the prediabetic stage completely prevented disease by impairing the expansion and function of autoreactive CD8+ T cells. These findings demonstrate that NKG2D is essential for disease progression and suggest a new therapeutic target for autoimmune type I diabetes.

AB - NKG2D is an activating receptor on CD8+ T cells and NK cells that has been implicated in immunity against tumors and microbial pathogens. Here we show that RAE-1 is present in prediabetic pancreas islets of NOD mice and that autoreactive CD8+ T cells infiltrating the pancreas express NKG2D. Treatment with a nondepleting anti-NKG2D monoclonal antibody (mAb) during the prediabetic stage completely prevented disease by impairing the expansion and function of autoreactive CD8+ T cells. These findings demonstrate that NKG2D is essential for disease progression and suggest a new therapeutic target for autoimmune type I diabetes.

UR - http://www.scopus.com/inward/record.url?scp=2942546678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942546678&partnerID=8YFLogxK

U2 - 10.1016/j.immuni.2004.05.008

DO - 10.1016/j.immuni.2004.05.008

M3 - Article

C2 - 15189740

AN - SCOPUS:2942546678

VL - 20

SP - 757

EP - 767

JO - Immunity

JF - Immunity

SN - 1074-7613

IS - 6

ER -